Global Finasteride (Oral Route) Market Growth 2026-2032
The global Finasteride (Oral Route) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
United States market for Finasteride (Oral Route) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Finasteride (Oral Route) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Finasteride (Oral Route) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Finasteride (Oral Route) players cover Merck, Sandoz, Actavis, Cipla, RelonChem, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Finasteride (Oral Route) Industry Forecast? looks at past sales and reviews total world Finasteride (Oral Route) sales in 2025, providing a comprehensive analysis by region and market sector of projected Finasteride (Oral Route) sales for 2026 through 2032. With Finasteride (Oral Route) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Finasteride (Oral Route) industry.
This Insight Report provides a comprehensive analysis of the global Finasteride (Oral Route) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Finasteride (Oral Route) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Finasteride (Oral Route) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Finasteride (Oral Route) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Finasteride (Oral Route).
This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride (Oral Route) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Finasteride, when taken orally, is a medication used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It is also prescribed to treat male pattern hair loss (androgenetic alopecia) in men. Finasteride works by inhibiting the action of the enzyme 5-alpha reductase, which converts the male hormone testosterone to dihydrotestosterone (DHT). By reducing DHT levels in the body, finasteride helps to shrink the prostate and promote hair regrowth in men with male pattern baldness. It is important to note that finasteride should only be taken as prescribed by a healthcare provider, as it can have side effects and may not be suitable for everyone.
United States market for Finasteride (Oral Route) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Finasteride (Oral Route) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Finasteride (Oral Route) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Finasteride (Oral Route) players cover Merck, Sandoz, Actavis, Cipla, RelonChem, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Finasteride (Oral Route) Industry Forecast? looks at past sales and reviews total world Finasteride (Oral Route) sales in 2025, providing a comprehensive analysis by region and market sector of projected Finasteride (Oral Route) sales for 2026 through 2032. With Finasteride (Oral Route) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Finasteride (Oral Route) industry.
This Insight Report provides a comprehensive analysis of the global Finasteride (Oral Route) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Finasteride (Oral Route) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Finasteride (Oral Route) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Finasteride (Oral Route) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Finasteride (Oral Route).
This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride (Oral Route) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1mg
- 5mg
- Urology
- Dermatology
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Sandoz
- Actavis
- Cipla
- RelonChem
- Dr. Reddy
- Accord Pharmaceuticals
- Hangzhou Kangenbei Pharmaceutical Co., Ltd
- Hunan Zhengqing Pharmaceutical Group Co., Ltd
- Tianfang Pharmaceutical Co., Ltd
- Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
- Zhejiang Xianju Pharmaceutical Co., Ltd
- Shanghai Hyundai Pharmaceutical Co., Ltd
- Hunan Baicao Pharmaceutical Co., Ltd
- Guangdong Yishu Pharmaceutical Co., Ltd
- CR SECCO Pharmaceutical Co., Ltd
- Shanghai Xinya Pharmaceutical Minhang Co., Ltd
- Renhetang Pharmaceutical Company Limited
- Runenberg Pharmaceuticals Ltd
- Nanjing Shenghe Pharmaceutical Co., Ltd
- Nanjing Sea Whale Pharmaceutical Co., Ltd
- What is the 10-year outlook for the global Finasteride (Oral Route) market?
- What factors are driving Finasteride (Oral Route) market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Finasteride (Oral Route) market opportunities vary by end market size?
- How does Finasteride (Oral Route) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Finasteride (Oral Route) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Finasteride (Oral Route) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Finasteride (Oral Route) by Country/Region, 2021, 2025 & 2032
2.2 Finasteride (Oral Route) Segment by Type
2.2.1 1mg
2.2.2 5mg
2.2.3 Finasteride (Oral Route) Sales by Type
2.2.3.1 Global Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Finasteride (Oral Route) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Finasteride (Oral Route) Sale Price by Type (2021-2026)
2.3 Finasteride (Oral Route) Segment by Application
2.3.1 Urology
2.3.2 Dermatology
2.3.3 Finasteride (Oral Route) Sales by Application
2.3.3.1 Global Finasteride (Oral Route) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Finasteride (Oral Route) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Finasteride (Oral Route) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Finasteride (Oral Route) Breakdown Data by Company
3.1.1 Global Finasteride (Oral Route) Annual Sales by Company (2021-2026)
3.1.2 Global Finasteride (Oral Route) Sales Market Share by Company (2021-2026)
3.2 Global Finasteride (Oral Route) Annual Revenue by Company (2021-2026)
3.2.1 Global Finasteride (Oral Route) Revenue by Company (2021-2026)
3.2.2 Global Finasteride (Oral Route) Revenue Market Share by Company (2021-2026)
3.3 Global Finasteride (Oral Route) Sale Price by Company
3.4 Key Manufacturers Finasteride (Oral Route) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Finasteride (Oral Route) Product Location Distribution
3.4.2 Players Finasteride (Oral Route) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FINASTERIDE (ORAL ROUTE) BY GEOGRAPHIC REGION
4.1 World Historic Finasteride (Oral Route) Market Size by Geographic Region (2021-2026)
4.1.1 Global Finasteride (Oral Route) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Finasteride (Oral Route) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Finasteride (Oral Route) Market Size by Country/Region (2021-2026)
4.2.1 Global Finasteride (Oral Route) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Finasteride (Oral Route) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Finasteride (Oral Route) Sales Growth
4.4 APAC Finasteride (Oral Route) Sales Growth
4.5 Europe Finasteride (Oral Route) Sales Growth
4.6 Middle East & Africa Finasteride (Oral Route) Sales Growth
5 AMERICAS
5.1 Americas Finasteride (Oral Route) Sales by Country
5.1.1 Americas Finasteride (Oral Route) Sales by Country (2021-2026)
5.1.2 Americas Finasteride (Oral Route) Revenue by Country (2021-2026)
5.2 Americas Finasteride (Oral Route) Sales by Type (2021-2026)
5.3 Americas Finasteride (Oral Route) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Finasteride (Oral Route) Sales by Region
6.1.1 APAC Finasteride (Oral Route) Sales by Region (2021-2026)
6.1.2 APAC Finasteride (Oral Route) Revenue by Region (2021-2026)
6.2 APAC Finasteride (Oral Route) Sales by Type (2021-2026)
6.3 APAC Finasteride (Oral Route) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Finasteride (Oral Route) by Country
7.1.1 Europe Finasteride (Oral Route) Sales by Country (2021-2026)
7.1.2 Europe Finasteride (Oral Route) Revenue by Country (2021-2026)
7.2 Europe Finasteride (Oral Route) Sales by Type (2021-2026)
7.3 Europe Finasteride (Oral Route) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Finasteride (Oral Route) by Country
8.1.1 Middle East & Africa Finasteride (Oral Route) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Finasteride (Oral Route) Revenue by Country (2021-2026)
8.2 Middle East & Africa Finasteride (Oral Route) Sales by Type (2021-2026)
8.3 Middle East & Africa Finasteride (Oral Route) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Finasteride (Oral Route)
10.3 Manufacturing Process Analysis of Finasteride (Oral Route)
10.4 Industry Chain Structure of Finasteride (Oral Route)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Finasteride (Oral Route) Distributors
11.3 Finasteride (Oral Route) Customer
12 WORLD FORECAST REVIEW FOR FINASTERIDE (ORAL ROUTE) BY GEOGRAPHIC REGION
12.1 Global Finasteride (Oral Route) Market Size Forecast by Region
12.1.1 Global Finasteride (Oral Route) Forecast by Region (2027-2032)
12.1.2 Global Finasteride (Oral Route) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Finasteride (Oral Route) Forecast by Type (2027-2032)
12.7 Global Finasteride (Oral Route) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Finasteride (Oral Route) Product Portfolios and Specifications
13.1.3 Merck Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Finasteride (Oral Route) Product Portfolios and Specifications
13.2.3 Sandoz Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 Actavis
13.3.1 Actavis Company Information
13.3.2 Actavis Finasteride (Oral Route) Product Portfolios and Specifications
13.3.3 Actavis Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Actavis Main Business Overview
13.3.5 Actavis Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Finasteride (Oral Route) Product Portfolios and Specifications
13.4.3 Cipla Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 RelonChem
13.5.1 RelonChem Company Information
13.5.2 RelonChem Finasteride (Oral Route) Product Portfolios and Specifications
13.5.3 RelonChem Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 RelonChem Main Business Overview
13.5.5 RelonChem Latest Developments
13.6 Dr. Reddy
13.6.1 Dr. Reddy Company Information
13.6.2 Dr. Reddy Finasteride (Oral Route) Product Portfolios and Specifications
13.6.3 Dr. Reddy Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dr. Reddy Main Business Overview
13.6.5 Dr. Reddy Latest Developments
13.7 Accord Pharmaceuticals
13.7.1 Accord Pharmaceuticals Company Information
13.7.2 Accord Pharmaceuticals Finasteride (Oral Route) Product Portfolios and Specifications
13.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Accord Pharmaceuticals Main Business Overview
13.7.5 Accord Pharmaceuticals Latest Developments
13.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
13.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
13.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Main Business Overview
13.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Latest Developments
13.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
13.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
13.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Main Business Overview
13.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Latest Developments
13.10 Tianfang Pharmaceutical Co., Ltd
13.10.1 Tianfang Pharmaceutical Co., Ltd Company Information
13.10.2 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Tianfang Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Tianfang Pharmaceutical Co., Ltd Latest Developments
13.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
13.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
13.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Main Business Overview
13.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Latest Developments
13.12 Zhejiang Xianju Pharmaceutical Co., Ltd
13.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
13.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Main Business Overview
13.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Latest Developments
13.13 Shanghai Hyundai Pharmaceutical Co., Ltd
13.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
13.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Main Business Overview
13.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Latest Developments
13.14 Hunan Baicao Pharmaceutical Co., Ltd
13.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
13.14.2 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Hunan Baicao Pharmaceutical Co., Ltd Main Business Overview
13.14.5 Hunan Baicao Pharmaceutical Co., Ltd Latest Developments
13.15 Guangdong Yishu Pharmaceutical Co., Ltd
13.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
13.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Main Business Overview
13.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Latest Developments
13.16 CR SECCO Pharmaceutical Co., Ltd
13.16.1 CR SECCO Pharmaceutical Co., Ltd Company Information
13.16.2 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 CR SECCO Pharmaceutical Co., Ltd Main Business Overview
13.16.5 CR SECCO Pharmaceutical Co., Ltd Latest Developments
13.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
13.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
13.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Main Business Overview
13.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Latest Developments
13.18 Renhetang Pharmaceutical Company Limited
13.18.1 Renhetang Pharmaceutical Company Limited Company Information
13.18.2 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product Portfolios and Specifications
13.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Renhetang Pharmaceutical Company Limited Main Business Overview
13.18.5 Renhetang Pharmaceutical Company Limited Latest Developments
13.19 Runenberg Pharmaceuticals Ltd
13.19.1 Runenberg Pharmaceuticals Ltd Company Information
13.19.2 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Runenberg Pharmaceuticals Ltd Main Business Overview
13.19.5 Runenberg Pharmaceuticals Ltd Latest Developments
13.20 Nanjing Shenghe Pharmaceutical Co., Ltd
13.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
13.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Main Business Overview
13.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Latest Developments
13.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
13.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
13.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Main Business Overview
13.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Finasteride (Oral Route) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Finasteride (Oral Route) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Finasteride (Oral Route) by Country/Region, 2021, 2025 & 2032
2.2 Finasteride (Oral Route) Segment by Type
2.2.1 1mg
2.2.2 5mg
2.2.3 Finasteride (Oral Route) Sales by Type
2.2.3.1 Global Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Finasteride (Oral Route) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Finasteride (Oral Route) Sale Price by Type (2021-2026)
2.3 Finasteride (Oral Route) Segment by Application
2.3.1 Urology
2.3.2 Dermatology
2.3.3 Finasteride (Oral Route) Sales by Application
2.3.3.1 Global Finasteride (Oral Route) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Finasteride (Oral Route) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Finasteride (Oral Route) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Finasteride (Oral Route) Breakdown Data by Company
3.1.1 Global Finasteride (Oral Route) Annual Sales by Company (2021-2026)
3.1.2 Global Finasteride (Oral Route) Sales Market Share by Company (2021-2026)
3.2 Global Finasteride (Oral Route) Annual Revenue by Company (2021-2026)
3.2.1 Global Finasteride (Oral Route) Revenue by Company (2021-2026)
3.2.2 Global Finasteride (Oral Route) Revenue Market Share by Company (2021-2026)
3.3 Global Finasteride (Oral Route) Sale Price by Company
3.4 Key Manufacturers Finasteride (Oral Route) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Finasteride (Oral Route) Product Location Distribution
3.4.2 Players Finasteride (Oral Route) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FINASTERIDE (ORAL ROUTE) BY GEOGRAPHIC REGION
4.1 World Historic Finasteride (Oral Route) Market Size by Geographic Region (2021-2026)
4.1.1 Global Finasteride (Oral Route) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Finasteride (Oral Route) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Finasteride (Oral Route) Market Size by Country/Region (2021-2026)
4.2.1 Global Finasteride (Oral Route) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Finasteride (Oral Route) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Finasteride (Oral Route) Sales Growth
4.4 APAC Finasteride (Oral Route) Sales Growth
4.5 Europe Finasteride (Oral Route) Sales Growth
4.6 Middle East & Africa Finasteride (Oral Route) Sales Growth
5 AMERICAS
5.1 Americas Finasteride (Oral Route) Sales by Country
5.1.1 Americas Finasteride (Oral Route) Sales by Country (2021-2026)
5.1.2 Americas Finasteride (Oral Route) Revenue by Country (2021-2026)
5.2 Americas Finasteride (Oral Route) Sales by Type (2021-2026)
5.3 Americas Finasteride (Oral Route) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Finasteride (Oral Route) Sales by Region
6.1.1 APAC Finasteride (Oral Route) Sales by Region (2021-2026)
6.1.2 APAC Finasteride (Oral Route) Revenue by Region (2021-2026)
6.2 APAC Finasteride (Oral Route) Sales by Type (2021-2026)
6.3 APAC Finasteride (Oral Route) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Finasteride (Oral Route) by Country
7.1.1 Europe Finasteride (Oral Route) Sales by Country (2021-2026)
7.1.2 Europe Finasteride (Oral Route) Revenue by Country (2021-2026)
7.2 Europe Finasteride (Oral Route) Sales by Type (2021-2026)
7.3 Europe Finasteride (Oral Route) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Finasteride (Oral Route) by Country
8.1.1 Middle East & Africa Finasteride (Oral Route) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Finasteride (Oral Route) Revenue by Country (2021-2026)
8.2 Middle East & Africa Finasteride (Oral Route) Sales by Type (2021-2026)
8.3 Middle East & Africa Finasteride (Oral Route) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Finasteride (Oral Route)
10.3 Manufacturing Process Analysis of Finasteride (Oral Route)
10.4 Industry Chain Structure of Finasteride (Oral Route)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Finasteride (Oral Route) Distributors
11.3 Finasteride (Oral Route) Customer
12 WORLD FORECAST REVIEW FOR FINASTERIDE (ORAL ROUTE) BY GEOGRAPHIC REGION
12.1 Global Finasteride (Oral Route) Market Size Forecast by Region
12.1.1 Global Finasteride (Oral Route) Forecast by Region (2027-2032)
12.1.2 Global Finasteride (Oral Route) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Finasteride (Oral Route) Forecast by Type (2027-2032)
12.7 Global Finasteride (Oral Route) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Finasteride (Oral Route) Product Portfolios and Specifications
13.1.3 Merck Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Finasteride (Oral Route) Product Portfolios and Specifications
13.2.3 Sandoz Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 Actavis
13.3.1 Actavis Company Information
13.3.2 Actavis Finasteride (Oral Route) Product Portfolios and Specifications
13.3.3 Actavis Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Actavis Main Business Overview
13.3.5 Actavis Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Finasteride (Oral Route) Product Portfolios and Specifications
13.4.3 Cipla Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 RelonChem
13.5.1 RelonChem Company Information
13.5.2 RelonChem Finasteride (Oral Route) Product Portfolios and Specifications
13.5.3 RelonChem Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 RelonChem Main Business Overview
13.5.5 RelonChem Latest Developments
13.6 Dr. Reddy
13.6.1 Dr. Reddy Company Information
13.6.2 Dr. Reddy Finasteride (Oral Route) Product Portfolios and Specifications
13.6.3 Dr. Reddy Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dr. Reddy Main Business Overview
13.6.5 Dr. Reddy Latest Developments
13.7 Accord Pharmaceuticals
13.7.1 Accord Pharmaceuticals Company Information
13.7.2 Accord Pharmaceuticals Finasteride (Oral Route) Product Portfolios and Specifications
13.7.3 Accord Pharmaceuticals Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Accord Pharmaceuticals Main Business Overview
13.7.5 Accord Pharmaceuticals Latest Developments
13.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
13.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
13.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Main Business Overview
13.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Latest Developments
13.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
13.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
13.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Main Business Overview
13.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Latest Developments
13.10 Tianfang Pharmaceutical Co., Ltd
13.10.1 Tianfang Pharmaceutical Co., Ltd Company Information
13.10.2 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.10.3 Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Tianfang Pharmaceutical Co., Ltd Main Business Overview
13.10.5 Tianfang Pharmaceutical Co., Ltd Latest Developments
13.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
13.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
13.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Main Business Overview
13.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Latest Developments
13.12 Zhejiang Xianju Pharmaceutical Co., Ltd
13.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
13.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Main Business Overview
13.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Latest Developments
13.13 Shanghai Hyundai Pharmaceutical Co., Ltd
13.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
13.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Main Business Overview
13.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Latest Developments
13.14 Hunan Baicao Pharmaceutical Co., Ltd
13.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
13.14.2 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.14.3 Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Hunan Baicao Pharmaceutical Co., Ltd Main Business Overview
13.14.5 Hunan Baicao Pharmaceutical Co., Ltd Latest Developments
13.15 Guangdong Yishu Pharmaceutical Co., Ltd
13.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
13.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Main Business Overview
13.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Latest Developments
13.16 CR SECCO Pharmaceutical Co., Ltd
13.16.1 CR SECCO Pharmaceutical Co., Ltd Company Information
13.16.2 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.16.3 CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 CR SECCO Pharmaceutical Co., Ltd Main Business Overview
13.16.5 CR SECCO Pharmaceutical Co., Ltd Latest Developments
13.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
13.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
13.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Main Business Overview
13.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Latest Developments
13.18 Renhetang Pharmaceutical Company Limited
13.18.1 Renhetang Pharmaceutical Company Limited Company Information
13.18.2 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product Portfolios and Specifications
13.18.3 Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Renhetang Pharmaceutical Company Limited Main Business Overview
13.18.5 Renhetang Pharmaceutical Company Limited Latest Developments
13.19 Runenberg Pharmaceuticals Ltd
13.19.1 Runenberg Pharmaceuticals Ltd Company Information
13.19.2 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.19.3 Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Runenberg Pharmaceuticals Ltd Main Business Overview
13.19.5 Runenberg Pharmaceuticals Ltd Latest Developments
13.20 Nanjing Shenghe Pharmaceutical Co., Ltd
13.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
13.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Main Business Overview
13.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Latest Developments
13.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
13.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
13.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
13.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Main Business Overview
13.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Finasteride (Oral Route) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Finasteride (Oral Route) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1mg
Table 4. Major Players of 5mg
Table 5. Global Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 6. Global Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Table 7. Global Finasteride (Oral Route) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Finasteride (Oral Route) Revenue Market Share by Type (2021-2026)
Table 9. Global Finasteride (Oral Route) Sale Price by Type (2021-2026) & (US$/Pcs)
Table 10. Global Finasteride (Oral Route) Sale by Application (2021-2026) & (K Pcs)
Table 11. Global Finasteride (Oral Route) Sale Market Share by Application (2021-2026)
Table 12. Global Finasteride (Oral Route) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Finasteride (Oral Route) Revenue Market Share by Application (2021-2026)
Table 14. Global Finasteride (Oral Route) Sale Price by Application (2021-2026) & (US$/Pcs)
Table 15. Global Finasteride (Oral Route) Sales by Company (2021-2026) & (K Pcs)
Table 16. Global Finasteride (Oral Route) Sales Market Share by Company (2021-2026)
Table 17. Global Finasteride (Oral Route) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Finasteride (Oral Route) Revenue Market Share by Company (2021-2026)
Table 19. Global Finasteride (Oral Route) Sale Price by Company (2021-2026) & (US$/Pcs)
Table 20. Key Manufacturers Finasteride (Oral Route) Producing Area Distribution and Sales Area
Table 21. Players Finasteride (Oral Route) Products Offered
Table 22. Finasteride (Oral Route) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Finasteride (Oral Route) Sales by Geographic Region (2021-2026) & (K Pcs)
Table 26. Global Finasteride (Oral Route) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Finasteride (Oral Route) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Finasteride (Oral Route) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Finasteride (Oral Route) Sales by Country/Region (2021-2026) & (K Pcs)
Table 30. Global Finasteride (Oral Route) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Finasteride (Oral Route) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Finasteride (Oral Route) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Finasteride (Oral Route) Sales by Country (2021-2026) & (K Pcs)
Table 34. Americas Finasteride (Oral Route) Sales Market Share by Country (2021-2026)
Table 35. Americas Finasteride (Oral Route) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 37. Americas Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 38. APAC Finasteride (Oral Route) Sales by Region (2021-2026) & (K Pcs)
Table 39. APAC Finasteride (Oral Route) Sales Market Share by Region (2021-2026)
Table 40. APAC Finasteride (Oral Route) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 42. APAC Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 43. Europe Finasteride (Oral Route) Sales by Country (2021-2026) & (K Pcs)
Table 44. Europe Finasteride (Oral Route) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 47. Middle East & Africa Finasteride (Oral Route) Sales by Country (2021-2026) & (K Pcs)
Table 48. Middle East & Africa Finasteride (Oral Route) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 50. Middle East & Africa Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Finasteride (Oral Route)
Table 52. Key Market Challenges & Risks of Finasteride (Oral Route)
Table 53. Key Industry Trends of Finasteride (Oral Route)
Table 54. Finasteride (Oral Route) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Finasteride (Oral Route) Distributors List
Table 57. Finasteride (Oral Route) Customer List
Table 58. Global Finasteride (Oral Route) Sales Forecast by Region (2027-2032) & (K Pcs)
Table 59. Global Finasteride (Oral Route) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Finasteride (Oral Route) Sales Forecast by Country (2027-2032) & (K Pcs)
Table 61. Americas Finasteride (Oral Route) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Finasteride (Oral Route) Sales Forecast by Region (2027-2032) & (K Pcs)
Table 63. APAC Finasteride (Oral Route) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Finasteride (Oral Route) Sales Forecast by Country (2027-2032) & (K Pcs)
Table 65. Europe Finasteride (Oral Route) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Finasteride (Oral Route) Sales Forecast by Country (2027-2032) & (K Pcs)
Table 67. Middle East & Africa Finasteride (Oral Route) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Finasteride (Oral Route) Sales Forecast by Type (2027-2032) & (K Pcs)
Table 69. Global Finasteride (Oral Route) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Finasteride (Oral Route) Sales Forecast by Application (2027-2032) & (K Pcs)
Table 71. Global Finasteride (Oral Route) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Finasteride (Oral Route) Product Portfolios and Specifications
Table 74. Merck Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Sandoz Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 78. Sandoz Finasteride (Oral Route) Product Portfolios and Specifications
Table 79. Sandoz Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 80. Sandoz Main Business
Table 81. Sandoz Latest Developments
Table 82. Actavis Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 83. Actavis Finasteride (Oral Route) Product Portfolios and Specifications
Table 84. Actavis Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 85. Actavis Main Business
Table 86. Actavis Latest Developments
Table 87. Cipla Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Finasteride (Oral Route) Product Portfolios and Specifications
Table 89. Cipla Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 90. Cipla Main Business
Table 91. Cipla Latest Developments
Table 92. RelonChem Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 93. RelonChem Finasteride (Oral Route) Product Portfolios and Specifications
Table 94. RelonChem Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 95. RelonChem Main Business
Table 96. RelonChem Latest Developments
Table 97. Dr. Reddy Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr. Reddy Finasteride (Oral Route) Product Portfolios and Specifications
Table 99. Dr. Reddy Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 100. Dr. Reddy Main Business
Table 101. Dr. Reddy Latest Developments
Table 102. Accord Pharmaceuticals Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 103. Accord Pharmaceuticals Finasteride (Oral Route) Product Portfolios and Specifications
Table 104. Accord Pharmaceuticals Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 105. Accord Pharmaceuticals Main Business
Table 106. Accord Pharmaceuticals Latest Developments
Table 107. Hangzhou Kangenbei Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 108. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 109. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 110. Hangzhou Kangenbei Pharmaceutical Co., Ltd Main Business
Table 111. Hangzhou Kangenbei Pharmaceutical Co., Ltd Latest Developments
Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 115. Hunan Zhengqing Pharmaceutical Group Co., Ltd Main Business
Table 116. Hunan Zhengqing Pharmaceutical Group Co., Ltd Latest Developments
Table 117. Tianfang Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 118. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 119. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 120. Tianfang Pharmaceutical Co., Ltd Main Business
Table 121. Tianfang Pharmaceutical Co., Ltd Latest Developments
Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Main Business
Table 126. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Latest Developments
Table 127. Zhejiang Xianju Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 128. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 129. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 130. Zhejiang Xianju Pharmaceutical Co., Ltd Main Business
Table 131. Zhejiang Xianju Pharmaceutical Co., Ltd Latest Developments
Table 132. Shanghai Hyundai Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 134. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 135. Shanghai Hyundai Pharmaceutical Co., Ltd Main Business
Table 136. Shanghai Hyundai Pharmaceutical Co., Ltd Latest Developments
Table 137. Hunan Baicao Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 138. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 139. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 140. Hunan Baicao Pharmaceutical Co., Ltd Main Business
Table 141. Hunan Baicao Pharmaceutical Co., Ltd Latest Developments
Table 142. Guangdong Yishu Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 143. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 144. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 145. Guangdong Yishu Pharmaceutical Co., Ltd Main Business
Table 146. Guangdong Yishu Pharmaceutical Co., Ltd Latest Developments
Table 147. CR SECCO Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 148. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 149. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 150. CR SECCO Pharmaceutical Co., Ltd Main Business
Table 151. CR SECCO Pharmaceutical Co., Ltd Latest Developments
Table 152. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 154. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 155. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Main Business
Table 156. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Latest Developments
Table 157. Renhetang Pharmaceutical Company Limited Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 158. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product Portfolios and Specifications
Table 159. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 160. Renhetang Pharmaceutical Company Limited Main Business
Table 161. Renhetang Pharmaceutical Company Limited Latest Developments
Table 162. Runenberg Pharmaceuticals Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 163. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 164. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 165. Runenberg Pharmaceuticals Ltd Main Business
Table 166. Runenberg Pharmaceuticals Ltd Latest Developments
Table 167. Nanjing Shenghe Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 168. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 169. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 170. Nanjing Shenghe Pharmaceutical Co., Ltd Main Business
Table 171. Nanjing Shenghe Pharmaceutical Co., Ltd Latest Developments
Table 172. Nanjing Sea Whale Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 173. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 174. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 175. Nanjing Sea Whale Pharmaceutical Co., Ltd Main Business
Table 176. Nanjing Sea Whale Pharmaceutical Co., Ltd Latest Developments
Table 1. Finasteride (Oral Route) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Finasteride (Oral Route) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1mg
Table 4. Major Players of 5mg
Table 5. Global Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 6. Global Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Table 7. Global Finasteride (Oral Route) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Finasteride (Oral Route) Revenue Market Share by Type (2021-2026)
Table 9. Global Finasteride (Oral Route) Sale Price by Type (2021-2026) & (US$/Pcs)
Table 10. Global Finasteride (Oral Route) Sale by Application (2021-2026) & (K Pcs)
Table 11. Global Finasteride (Oral Route) Sale Market Share by Application (2021-2026)
Table 12. Global Finasteride (Oral Route) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Finasteride (Oral Route) Revenue Market Share by Application (2021-2026)
Table 14. Global Finasteride (Oral Route) Sale Price by Application (2021-2026) & (US$/Pcs)
Table 15. Global Finasteride (Oral Route) Sales by Company (2021-2026) & (K Pcs)
Table 16. Global Finasteride (Oral Route) Sales Market Share by Company (2021-2026)
Table 17. Global Finasteride (Oral Route) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Finasteride (Oral Route) Revenue Market Share by Company (2021-2026)
Table 19. Global Finasteride (Oral Route) Sale Price by Company (2021-2026) & (US$/Pcs)
Table 20. Key Manufacturers Finasteride (Oral Route) Producing Area Distribution and Sales Area
Table 21. Players Finasteride (Oral Route) Products Offered
Table 22. Finasteride (Oral Route) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Finasteride (Oral Route) Sales by Geographic Region (2021-2026) & (K Pcs)
Table 26. Global Finasteride (Oral Route) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Finasteride (Oral Route) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Finasteride (Oral Route) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Finasteride (Oral Route) Sales by Country/Region (2021-2026) & (K Pcs)
Table 30. Global Finasteride (Oral Route) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Finasteride (Oral Route) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Finasteride (Oral Route) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Finasteride (Oral Route) Sales by Country (2021-2026) & (K Pcs)
Table 34. Americas Finasteride (Oral Route) Sales Market Share by Country (2021-2026)
Table 35. Americas Finasteride (Oral Route) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 37. Americas Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 38. APAC Finasteride (Oral Route) Sales by Region (2021-2026) & (K Pcs)
Table 39. APAC Finasteride (Oral Route) Sales Market Share by Region (2021-2026)
Table 40. APAC Finasteride (Oral Route) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 42. APAC Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 43. Europe Finasteride (Oral Route) Sales by Country (2021-2026) & (K Pcs)
Table 44. Europe Finasteride (Oral Route) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 47. Middle East & Africa Finasteride (Oral Route) Sales by Country (2021-2026) & (K Pcs)
Table 48. Middle East & Africa Finasteride (Oral Route) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Finasteride (Oral Route) Sales by Type (2021-2026) & (K Pcs)
Table 50. Middle East & Africa Finasteride (Oral Route) Sales by Application (2021-2026) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Finasteride (Oral Route)
Table 52. Key Market Challenges & Risks of Finasteride (Oral Route)
Table 53. Key Industry Trends of Finasteride (Oral Route)
Table 54. Finasteride (Oral Route) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Finasteride (Oral Route) Distributors List
Table 57. Finasteride (Oral Route) Customer List
Table 58. Global Finasteride (Oral Route) Sales Forecast by Region (2027-2032) & (K Pcs)
Table 59. Global Finasteride (Oral Route) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Finasteride (Oral Route) Sales Forecast by Country (2027-2032) & (K Pcs)
Table 61. Americas Finasteride (Oral Route) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Finasteride (Oral Route) Sales Forecast by Region (2027-2032) & (K Pcs)
Table 63. APAC Finasteride (Oral Route) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Finasteride (Oral Route) Sales Forecast by Country (2027-2032) & (K Pcs)
Table 65. Europe Finasteride (Oral Route) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Finasteride (Oral Route) Sales Forecast by Country (2027-2032) & (K Pcs)
Table 67. Middle East & Africa Finasteride (Oral Route) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Finasteride (Oral Route) Sales Forecast by Type (2027-2032) & (K Pcs)
Table 69. Global Finasteride (Oral Route) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Finasteride (Oral Route) Sales Forecast by Application (2027-2032) & (K Pcs)
Table 71. Global Finasteride (Oral Route) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Finasteride (Oral Route) Product Portfolios and Specifications
Table 74. Merck Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Sandoz Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 78. Sandoz Finasteride (Oral Route) Product Portfolios and Specifications
Table 79. Sandoz Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 80. Sandoz Main Business
Table 81. Sandoz Latest Developments
Table 82. Actavis Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 83. Actavis Finasteride (Oral Route) Product Portfolios and Specifications
Table 84. Actavis Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 85. Actavis Main Business
Table 86. Actavis Latest Developments
Table 87. Cipla Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 88. Cipla Finasteride (Oral Route) Product Portfolios and Specifications
Table 89. Cipla Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 90. Cipla Main Business
Table 91. Cipla Latest Developments
Table 92. RelonChem Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 93. RelonChem Finasteride (Oral Route) Product Portfolios and Specifications
Table 94. RelonChem Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 95. RelonChem Main Business
Table 96. RelonChem Latest Developments
Table 97. Dr. Reddy Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 98. Dr. Reddy Finasteride (Oral Route) Product Portfolios and Specifications
Table 99. Dr. Reddy Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 100. Dr. Reddy Main Business
Table 101. Dr. Reddy Latest Developments
Table 102. Accord Pharmaceuticals Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 103. Accord Pharmaceuticals Finasteride (Oral Route) Product Portfolios and Specifications
Table 104. Accord Pharmaceuticals Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 105. Accord Pharmaceuticals Main Business
Table 106. Accord Pharmaceuticals Latest Developments
Table 107. Hangzhou Kangenbei Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 108. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 109. Hangzhou Kangenbei Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 110. Hangzhou Kangenbei Pharmaceutical Co., Ltd Main Business
Table 111. Hangzhou Kangenbei Pharmaceutical Co., Ltd Latest Developments
Table 112. Hunan Zhengqing Pharmaceutical Group Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 113. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 114. Hunan Zhengqing Pharmaceutical Group Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 115. Hunan Zhengqing Pharmaceutical Group Co., Ltd Main Business
Table 116. Hunan Zhengqing Pharmaceutical Group Co., Ltd Latest Developments
Table 117. Tianfang Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 118. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 119. Tianfang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 120. Tianfang Pharmaceutical Co., Ltd Main Business
Table 121. Tianfang Pharmaceutical Co., Ltd Latest Developments
Table 122. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 123. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 124. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 125. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Main Business
Table 126. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Latest Developments
Table 127. Zhejiang Xianju Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 128. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 129. Zhejiang Xianju Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 130. Zhejiang Xianju Pharmaceutical Co., Ltd Main Business
Table 131. Zhejiang Xianju Pharmaceutical Co., Ltd Latest Developments
Table 132. Shanghai Hyundai Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 134. Shanghai Hyundai Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 135. Shanghai Hyundai Pharmaceutical Co., Ltd Main Business
Table 136. Shanghai Hyundai Pharmaceutical Co., Ltd Latest Developments
Table 137. Hunan Baicao Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 138. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 139. Hunan Baicao Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 140. Hunan Baicao Pharmaceutical Co., Ltd Main Business
Table 141. Hunan Baicao Pharmaceutical Co., Ltd Latest Developments
Table 142. Guangdong Yishu Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 143. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 144. Guangdong Yishu Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 145. Guangdong Yishu Pharmaceutical Co., Ltd Main Business
Table 146. Guangdong Yishu Pharmaceutical Co., Ltd Latest Developments
Table 147. CR SECCO Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 148. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 149. CR SECCO Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 150. CR SECCO Pharmaceutical Co., Ltd Main Business
Table 151. CR SECCO Pharmaceutical Co., Ltd Latest Developments
Table 152. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 154. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 155. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Main Business
Table 156. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Latest Developments
Table 157. Renhetang Pharmaceutical Company Limited Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 158. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Product Portfolios and Specifications
Table 159. Renhetang Pharmaceutical Company Limited Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 160. Renhetang Pharmaceutical Company Limited Main Business
Table 161. Renhetang Pharmaceutical Company Limited Latest Developments
Table 162. Runenberg Pharmaceuticals Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 163. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 164. Runenberg Pharmaceuticals Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 165. Runenberg Pharmaceuticals Ltd Main Business
Table 166. Runenberg Pharmaceuticals Ltd Latest Developments
Table 167. Nanjing Shenghe Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 168. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 169. Nanjing Shenghe Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 170. Nanjing Shenghe Pharmaceutical Co., Ltd Main Business
Table 171. Nanjing Shenghe Pharmaceutical Co., Ltd Latest Developments
Table 172. Nanjing Sea Whale Pharmaceutical Co., Ltd Basic Information, Finasteride (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 173. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Product Portfolios and Specifications
Table 174. Nanjing Sea Whale Pharmaceutical Co., Ltd Finasteride (Oral Route) Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2021-2026)
Table 175. Nanjing Sea Whale Pharmaceutical Co., Ltd Main Business
Table 176. Nanjing Sea Whale Pharmaceutical Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Finasteride (Oral Route)
Figure 2. Finasteride (Oral Route) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Finasteride (Oral Route) Sales Growth Rate 2021-2032 (K Pcs)
Figure 7. Global Finasteride (Oral Route) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Finasteride (Oral Route) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Finasteride (Oral Route) Sales Market Share by Country/Region (2025)
Figure 10. Finasteride (Oral Route) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1mg
Figure 12. Product Picture of 5mg
Figure 13. Global Finasteride (Oral Route) Sales Market Share by Type in 2026
Figure 14. Global Finasteride (Oral Route) Revenue Market Share by Type (2021-2026)
Figure 15. Finasteride (Oral Route) Consumed in Urology
Figure 16. Global Finasteride (Oral Route) Market: Urology (2021-2026) & (K Pcs)
Figure 17. Finasteride (Oral Route) Consumed in Dermatology
Figure 18. Global Finasteride (Oral Route) Market: Dermatology (2021-2026) & (K Pcs)
Figure 19. Global Finasteride (Oral Route) Sale Market Share by Application (2025)
Figure 20. Global Finasteride (Oral Route) Revenue Market Share by Application in 2026
Figure 21. Finasteride (Oral Route) Sales by Company in 2026 (K Pcs)
Figure 22. Global Finasteride (Oral Route) Sales Market Share by Company in 2026
Figure 23. Finasteride (Oral Route) Revenue by Company in 2026 ($ millions)
Figure 24. Global Finasteride (Oral Route) Revenue Market Share by Company in 2026
Figure 25. Global Finasteride (Oral Route) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Finasteride (Oral Route) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 28. Americas Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 29. APAC Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 30. APAC Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 31. Europe Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 32. Europe Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 34. Middle East & Africa Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 35. Americas Finasteride (Oral Route) Sales Market Share by Country in 2026
Figure 36. Americas Finasteride (Oral Route) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 38. Americas Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 39. United States Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Finasteride (Oral Route) Sales Market Share by Region in 2026
Figure 44. APAC Finasteride (Oral Route) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 46. APAC Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 47. China Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Finasteride (Oral Route) Sales Market Share by Country in 2026
Figure 55. Europe Finasteride (Oral Route) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 57. Europe Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 58. Germany Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Finasteride (Oral Route) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Finasteride (Oral Route) in 2026
Figure 72. Manufacturing Process Analysis of Finasteride (Oral Route)
Figure 73. Industry Chain Structure of Finasteride (Oral Route)
Figure 74. Channels of Distribution
Figure 75. Global Finasteride (Oral Route) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Finasteride (Oral Route) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Finasteride (Oral Route) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Finasteride (Oral Route) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Finasteride (Oral Route) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Finasteride (Oral Route) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Finasteride (Oral Route)
Figure 2. Finasteride (Oral Route) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Finasteride (Oral Route) Sales Growth Rate 2021-2032 (K Pcs)
Figure 7. Global Finasteride (Oral Route) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Finasteride (Oral Route) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Finasteride (Oral Route) Sales Market Share by Country/Region (2025)
Figure 10. Finasteride (Oral Route) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1mg
Figure 12. Product Picture of 5mg
Figure 13. Global Finasteride (Oral Route) Sales Market Share by Type in 2026
Figure 14. Global Finasteride (Oral Route) Revenue Market Share by Type (2021-2026)
Figure 15. Finasteride (Oral Route) Consumed in Urology
Figure 16. Global Finasteride (Oral Route) Market: Urology (2021-2026) & (K Pcs)
Figure 17. Finasteride (Oral Route) Consumed in Dermatology
Figure 18. Global Finasteride (Oral Route) Market: Dermatology (2021-2026) & (K Pcs)
Figure 19. Global Finasteride (Oral Route) Sale Market Share by Application (2025)
Figure 20. Global Finasteride (Oral Route) Revenue Market Share by Application in 2026
Figure 21. Finasteride (Oral Route) Sales by Company in 2026 (K Pcs)
Figure 22. Global Finasteride (Oral Route) Sales Market Share by Company in 2026
Figure 23. Finasteride (Oral Route) Revenue by Company in 2026 ($ millions)
Figure 24. Global Finasteride (Oral Route) Revenue Market Share by Company in 2026
Figure 25. Global Finasteride (Oral Route) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Finasteride (Oral Route) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 28. Americas Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 29. APAC Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 30. APAC Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 31. Europe Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 32. Europe Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Finasteride (Oral Route) Sales 2021-2026 (K Pcs)
Figure 34. Middle East & Africa Finasteride (Oral Route) Revenue 2021-2026 ($ millions)
Figure 35. Americas Finasteride (Oral Route) Sales Market Share by Country in 2026
Figure 36. Americas Finasteride (Oral Route) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 38. Americas Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 39. United States Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Finasteride (Oral Route) Sales Market Share by Region in 2026
Figure 44. APAC Finasteride (Oral Route) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 46. APAC Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 47. China Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Finasteride (Oral Route) Sales Market Share by Country in 2026
Figure 55. Europe Finasteride (Oral Route) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 57. Europe Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 58. Germany Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Finasteride (Oral Route) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Finasteride (Oral Route) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Finasteride (Oral Route) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Finasteride (Oral Route) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Finasteride (Oral Route) in 2026
Figure 72. Manufacturing Process Analysis of Finasteride (Oral Route)
Figure 73. Industry Chain Structure of Finasteride (Oral Route)
Figure 74. Channels of Distribution
Figure 75. Global Finasteride (Oral Route) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Finasteride (Oral Route) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Finasteride (Oral Route) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Finasteride (Oral Route) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Finasteride (Oral Route) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Finasteride (Oral Route) Revenue Market Share Forecast by Application (2027-2032)
